Evidence map›Paper›PMID 35424257›Full record

ArticleRSC advances2021

Synthesis of new pyridines with sulfonamide moiety

Morteza Torabi, Meysam Yarie, Mohammad Ali Zolfigol, Shamila Rouhani, Shohreh Azizi, Temitope O Olomola, Malik Maaza, Titus A M Msagati

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Morteza TorabiDepartment of Organic Chemistry, Faculty of Chemistry, Bu-Ali Sina University Hamedan 6517838683 Iran myari.5266@gmail.com m.yarie92@basu.ac.ir.
Meysam YarieDepartment of Organic Chemistry, Faculty of Chemistry, Bu-Ali Sina University Hamedan 6517838683 Iran myari.5266@gmail.com m.yarie92@basu.ac.ir.ORCID https://orcid.org/0000-0002-7129-0776
Mohammad Ali ZolfigolDepartment of Organic Chemistry, Faculty of Chemistry, Bu-Ali Sina University Hamedan 6517838683 Iran myari.5266@gmail.com m.yarie92@basu.ac.ir.ORCID https://orcid.org/0000-0002-4970-8646
Shamila RouhaniInstitute of Nanotechnology and Water Sustainability (iNanoWS), College of Science, Engineering and Technology, University of South Africa Johannesburg 1709 South Africa.
Shohreh AziziUNESCO-UNISA Africa Chair in Nanosciences and Nanotechnology, College of Graduate Studies, University of South Africa Muckleneuk Ridge, PO Box 392 Pretoria South Africa.ORCID https://orcid.org/0000-0003-0419-9953
Temitope O OlomolaDepartment of Chemistry, Obafemi Awolowo University Ile-Ife 220005 Nigeria.
Malik MaazaUNESCO-UNISA Africa Chair in Nanosciences and Nanotechnology, College of Graduate Studies, University of South Africa Muckleneuk Ridge, PO Box 392 Pretoria South Africa.
Titus A M MsagatiInstitute of Nanotechnology and Water Sustainability (iNanoWS), College of Science, Engineering and Technology, University of South Africa Johannesburg 1709 South Africa.ORCID https://orcid.org/0000-0002-9621-5051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we reported the synthesis of a novel quinoline-based dendrimer-like ionic liquid. After characterization of the mentioned ionic liquid with suitable techniques such as Fourier transform infrared spectroscopy (FT-IR), energy dispersive X-ray spectroscopy (EDX), elemental mapping, thermogravimetric analysis (TGA) and derivative thermogravimetry (DTG), its catalytic performance was investigated in the synthesis of new pyridines with sulfonamide moiety

Identifiers

PMID35424257
PMCPMC8693819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.